Resveratrol, a remarkable inhibitor of ribonucleotide reductase

FEBS Letters

Volumn 421, Issue 3, 1998, Pages 277-279

  Fontecave, Marc ^a   Lepoivre, Michel ^b   Elleingand, Eric ^a   Gerez, Catherine ^a   Guittet, Olivier ^b  

^a UNIV GRENOBLE ALPES   (France)

^b CNRS   (France)

Author keywords

Anticancer agent; Resveratrol; Ribonucleotide reductase; Tyrosyl radical

Indexed keywords

RESVERATROL; RIBONUCLEOTIDE REDUCTASE;

ARTICLE; CANCER CHEMOTHERAPY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; DRUG ANALYSIS; ELECTRON SPIN RESONANCE; ENZYME INHIBITION; GRAPE; HEART DISEASE; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; WINE;

ANIMALS; DNA, NEOPLASM; ENZYME INHIBITORS; FREE RADICALS; HUMANS; MICE; NUCLEIC ACID SYNTHESIS INHIBITORS; RECOMBINANT FUSION PROTEINS; RIBONUCLEOTIDE REDUCTASES; STILBENES; TUMOR CELLS, CULTURED; TYROSINE;

MAMMALIA; VITACEAE; VITIS SP.;

EID: 0032536187     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)01572-X     Document Type: Article

References (21)

1. Soleas G.J., Diamandis E.P., Goldberg D.M. Clin. Biochem. 30:1997;91-113.
2. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W.W., Fong H.H.S., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Science. 275:1997;218-220.
3. Reichard P. Biochemistry. 26:1987;3245-3248.
4. Sjöberg, B.-M. (1995) in: Nucleic Acids and Molecular Biology (Eckstein, F. and Lilley, D.M.J., Eds.), Vol. 9, pp. 192-221, Springer-Verlag Berlin, Heidelberg.
5. Stubbe J., van der Donk W.A. Chem. Biol. 2:1995;793-801.
6. Robins M.J., Samano M.C., Samano V. Nucleosides Nucleotides. 14:1995;485-493.
7. Abbruzzese J.L., Plunkett W., et al. J. Clin. Oncol. 9:1991;491-498.
8. McCarthy, J.R. and Sunkara, P.S. (1995) in: Chemical and Structural Approaches to Rational Drug Design (Weiner, D.B. and Wlliams, W.B., Eds.), pp. 3-32, CRC Press, Boca Raton, FL.
9. Mann G.J., Gräslund A., Ochiai E.I., Ingemarson R., Thelander L. Biochemistry. 30:1991;1939-1947.
10. Kjöller Larsen I., Sjöberg B.-M., Thelander L. Eur. J. Biochem. 125:1982;75-81.
11. Pötsch S., Drechsler H., Liermann B., Gräslund A., Lassmann G. Mol. Pharmacol. 45:1994;792-796.
12. Gao W.Y., Cara A., Gallo R.C., Lori F. Proc. Natl. Acad. Sci. USA. 90:1993;8925-8928.
13. Lori F., Malykh A., Cara A., Sun D., Weinstein J.N., Lisziewicz J., Gallo R.C. Science. 266:1994;801-805.
14. Gao W.-Y., Johns D.G., Chokekijchai S., Mitsuya H. Proc. Natl. Acad. Sci. USA. 92:1995;8333-8337.
15. Bradford M.M. Anal. Biochem. 72:1976;248-254.
16. Lepoivre M., Flaman J.-M., Bobé P., Lemaire G., Henry Y. J. Biol. Chem. 269:1994;21891-21897.
17. Lepoivre M., Chenais B., Yapo A., Lemaire G., Thelander L., Tenu J.P. J. Biol. Chem. 265:1990;14143-14149.
18. Elford H.L., Wampler G.L., van't Riet B. Cancer Res. 39:1979;844-851.
19. Bianchi V., Borella P., Alderazzo F., Ferraro P., Chieco Bianchi L., Reichard P. Proc. Natl. Acad. Sci. USA. 91:1994;8403-8407.
20. Thelander L., Gräslund A. J. Biol. Chem. 258:1983;4063-4066.
21. Liermann B., Lassmann G., Langen P. Free Radical Biol. Med. 9:1990;1-4.